DES Lawsuit Update: The Rottenstein Law Group Is Encouraged By Settlement Between Victims, Eli Lilly

Diethylstilbestrol (DES) first showed up on the market about 60 years ago and was pulled off the market 20 years later, but it has recently been the subject of a series of lawsuits, according to the Associated Press. The Rottenstein Law Group, which maintains a DES Lawsuit Information Center, is encouraged by what one recent settlement outcome could mean for others who believe the drug has harmed them.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Settlements are a positive outcome for all the women who believe that they have been injured by the drug and who are deciding whether to file a DES lawsuit.

(PRWEB) February 04, 2013

Diethylstilbestrol (DES) first showed up on the market about 60 years ago and was pulled off the market 20 years later, but it has recently been the subject of at least one major lawsuit (1:11-cv-10152-MBB in the U.S. District Court for the District of Massachusetts). The Rottenstein Law Group, which maintains a DES Lawsuit Information Center, is encouraged by what one recent settlement outcome could mean for others who believe the drug has harmed them.

The Melnick sisters of Boston sued manufacturer Eli Lilly, alleging that the breast cancer they all have was caused by the synthetic hormone DES their mother took during pregnancy in the 1950s. The case went to trial in the first week of January 2013, but on the second day of testimony a settlement was announced, according to the Associated Press. This is the first of a number of cases set to go to trial. Neither parties would comment on the settlement amount.

About 51 women, including the Melnick sisters, filed suits in Boston against a dozen manufacturers or marketers of the drug, according to the AP. From the 1940s to the early 1970s, doctors prescribed DES to millions of pregnant women to prevent problems such as miscarriages and premature births. In the 1970s, according to the AP, the drug was pulled off the market after it was linked to vaginal cancer in the women who used it.

“Settlements are a positive outcome for all the women who believe that they have been injured by the drug and who are deciding whether to file a DES lawsuit,” said Rochelle Rottenstein, principal of the Rottenstein Law Group.

About THE ROTTENSTEIN LAW GROUP
The Rottenstein Law Group is a New York-based firm that represents clients nationwide in mass tort actions. The firm was founded by Rochelle Rottenstein, who has more than two decades of experience as a lawyer, to represent clients hurt by defective medical devices. (Attorney advertising. Prior results do not guarantee a similar outcome.)

Contact:
The Rottenstein Law Group, LLP
Rochelle Rottenstein, Esq.
321 W. 44th Street
# 804
New York NY 10036
(212) 933-9500 (office phone)
(212) 933-9980 (facsimile)
rochelle (at) rotlaw (dot) com
http://www.rotlaw.com
http://www.rotlaw.com/des/